Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Pain 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Cancer Pain 1

Interventions

Cytarabine 184Cyclophosphamide 176fludarabine 146Azacitidine 121venetoclax 115fludarabine phosphate 104Rituximab 80Decitabine 74Filgrastim 58Specimen Handling 55Etoposide 55Lenalidomide 47Biopsy 45Dexamethasone 41Methotrexate 40Bortezomib 40Mitoxantrone 39Granulocyte Colony-Stimulating Factor 39Daunorubicin 39Vincristine 37Melphalan 36ibrutinib 35Tacrolimus 35Dasatinib 34Whole-Body Irradiation 32Clofarabine 32Peripheral Blood Stem Cell Transplantation 31Mycophenolic Acid 31Injections 31Idarubicin 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sodium Bicarbonate × Other hematologic neoplasm × Clear all
NCT01846429 2015-06-04

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Terminated
9 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cancer Pain, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡